Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer

類似資料

• Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer
  著者:: Priceman, Saul J., 等
  出版事項: (2017)
• Development of HER2-specific chimeric antigen receptor T cells for the treatment of breast-to-brain metastasis
  著者:: Priceman, Saul, 等
  出版事項: (2015)
• Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
  著者:: Park, Anthony K, 等
  出版事項: (2015)
• Smart CARs Engineered for Cancer Immunotherapy
  著者:: Priceman, Saul J., 等
  出版事項: (2015)
• PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial
  著者:: Mark N. Stein, 等
  出版事項: (2024-12-01)